Gene · 1075
Papers2,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Papillon-Lefevre syndrome in twelve Egyptian patients: Five novel CTSC variants and functional characterization of a missense variant and its effect on splicing. | Arch Oral Biol | 2024 | 38104461 | PubTator, text mining | PubMed |
| Multiomic profiling reveals metabolic alterations mediating aberrant platelet activity and inflammation in myeloproliferative neoplasms. | J Clin Invest | 2024 | 38060311 | PubTator, text mining | PubMed |
| MLKL polymerization-induced lysosomal membrane permeabilization promotes necroptosis. | Cell Death Differ | 2024 | 37996483 | PubTator, text mining | PubMed |
| Identification of a novel frameshift mutation in cathepsin C gene in a patient with coexisting Papillon-Lefevre syndrome and rheumatoid arthritis. | J Eur Acad Dermatol Venereol | 2024 | 37983952 | PubTator, text mining | PubMed |
| CTSC promoted the migration and invasion of glioma cells via activation of STAT3/SERPINA3 axis. | Gene | 2024 | 37925117 | PubTator, text mining | PubMed |
| Human vascular smooth muscle cells utilise chymase for the atypical cleavage and activation of Interleukin-1β. | Atherosclerosis | 2024 | 37821269 | PubTator, text mining | PubMed |
| Cathepsin C role in inflammatory gastroenterological, renal, rheumatic, and pulmonary disorders. | Biochimie | 2024 | 37758158 | PubTator, text mining | PubMed |
| Possible relation of cathepsin C activity and seasonal fluctuation of skin lesions in Papillon-Lefèvre syndrome. | Br J Dermatol | 2024 | 37757845 | PubTator, text mining | PubMed |
| Periodontal Effects of the Reversible Dipeptidyl Peptidase 1 Inhibitor Brensocatib in Bronchiectasis. | JDR Clin Trans Res | 2024 | 37746735 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals the evolution of immune molecules across multiple vertebrate species. | J Adv Res | 2024 | 36871615 | PubTator, text mining | PubMed |
| Differential responses of selectively bred mussels (Perna canaliculus) to heat stress-survival, immunology, gene expression and microbiome diversity. | Front Physiol | 2023 | 38425477 | PubTator, text mining | PubMed |
| The Functional Roles of MDSCs in Severe COVID-19 Pathogenesis. | Viruses | 2023 | 38257728 | PubTator, text mining | PubMed |
| Anticancer Activity of the Marine Triterpene Glycoside Cucumarioside A2-2 in Human Prostate Cancer Cells. | Mar Drugs | 2023 | 38248645 | PubTator, text mining | PubMed |
| Leveraging technology-driven strategies to untangle omics big data: circumventing roadblocks in clinical facets of oral cancer. | Front Oncol | 2023 | 38234400 | PubTator, text mining | PubMed |
| Andrographolide Alleviates Oxidative Damage and Inhibits Apoptosis Induced by IHNV Infection via CTSK/BCL2/Cytc Axis. | Int J Mol Sci | 2023 | 38203479 | PubTator, text mining | PubMed |
| Key Factors in the Complex and Coordinated Network of Skin Keratinization: Their Significance and Involvement in Common Skin Conditions. | Int J Mol Sci | 2023 | 38203406 | PubTator, text mining | PubMed |
| Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease. | Front Immunol | 2023 | 38162644 | PubTator, text mining | PubMed |
| Agonistic Bivalent Human scFvs-Fcγ Fusion Antibodies to OX40 Ectodomain Enhance T Cell Activities against Cancer. | Vaccines (Basel) | 2023 | 38140230 | PubTator, text mining | PubMed |
| Knockouts of TNFRSF1A and TNFRSF1B Genes in K562 Cell Line Lead to Diverse Long-Lasting Responses to TNF-α. | Int J Mol Sci | 2023 | 38138998 | PubTator, text mining | PubMed |
| Drug Therapies for Diabetes. | Int J Mol Sci | 2023 | 38138975 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1075/papers?page=11